Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Cleveland Clinic | OTHER |
Not provided
Not provided
Not provided
In this study 100 patients due to undergo surgery that will result in an ostomy will be provided with the Alfred SmartBag system. The system encompasses a pouch, a baseplate that can track the volumetric filling of the pouch through integrated thermistor and capacitive sensors and potential leakage and skin irritation development through integrated thermistors in the wafer.
While patients with ileostomy have a risk of dehydration, early identification of those at greater risk may lead to home intervention and decreasing hospital readmission. Decreased readmissions ultimately leads to faster post-operative recovery, decreased risk of complications associated with readmissions (e.i. nosocomial infection, pneumonia, etc.) and decreased healthcare costs. Also evaluating the patients for possible stoma related complications in real time will help in treating them in a timely manner.
Sample size The number of subjects planned to enroll in the study is 100. It is plan to enroll 4 participants per month. Participants will be part of the study from the date of consent to the date when complete the follow-up at 90 days post-surgery.
Selection and screening of potential participants Patients scheduled for office visit with staff physician who will be undergoing to colorectal surgery with new ileostomy creation at the Cleveland Clinic, Main Campus.
Withdraws:
Research team:
Principal investigator, co-investigators, research coordinator, nurse (care coordinator), sponsor's representative must be part of the study in IRB and must be compliant with research policies. In addition, everyone in the team must complete CITI and HIPAA in Human Subject Research training courses before engaging in any research activity. No one can take active role in the study without previous documentation and approval by IRB.
Participant enrollment During the preoperative period (average time within 30 days prior to the surgery), eligible patients will be invited to participate in the study by the clinical staff. First, staff physician or clinical personnel will introduce the study. If a patient is interested, the Research Coordinator will explain the study in detail, answer any questions, and provide the informed consent in a quiet clinical setting. If a patient agrees to participate, he/she will sign the informed consent.
Study procedures:
At any time, complications, unanticipated problems, adverse effects, phone calls, 30-day post-operative report will be documented in logs according to standard practices or in formats included in Appendix 2; table 2 (p.30-31).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SmartBag arm | Experimental | The Alfred SmartBag System will be placed on the ostomy site during surgery. The system will be used to wirelessly monitor ostomy function in the hospital setting and the patient will otherwise receive the standard of care. At discharge the patient will continue to use the Alfred SmartBag System and ostomy function will be monitored by the research and clinical teams remotely. If participant's output is (i) less than 50mL or greater than 1500mL per day or (ii) greater than 1200mL in two days; the mobile app will alert not only the participant but also the clinical staff (nurse). Participants will also receive support from a 'Patient Coach', a trained health coach who is also an ostomy patient to provide quality of life support. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Alfred SmartBag | Device | The Alfred SmartBag encompasses a pouch, a baseplate, and a hub, is intended to be used as a continuous ostomy monitoring system by tracking the volumetric filling of the pouch through integrated thermistor and capacitive sensors and potential leakage and skin irritation development through integrated thermistors in the wafer. The Alfred SmartBag system is indicated for daily use for both in-patient and out-patient settings to provide information to patient and medical professionals. The data is intended to aid patient self-management and to alert the clinical team to changes in the patient condition that may warrant specific intervention. |
| Measure | Description | Time Frame |
|---|---|---|
| Unplanned hospital readmission within 30 days of surgery | Unplanned hospital readmission will be determined from the hospital patient record. This will be checked by the research team on the 30th postoperative day. | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Unplanned hospital readmission within 60 and 90 days of surgery | Unplanned hospital readmission will be determined from the hospital patient record. This will be checked by the research team on the 60th and 90th postoperative day. | 60 and 90 days |
| The incidence of high or low output stoma (output <50ml for 1 day, output >1500ml for 1 day or for >1200ml for 2 consecutive days within 30, 60 and 90 days of surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kavita Elliott | Contact | 2164447493 | Elliotk4@ccf.org |
| Name | Affiliation | Role |
|---|---|---|
| Emre Gorgun, MD | The Cleveland Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cleveland Clinic, Department of Colorectal Surgery | Recruiting | Cleveland | Ohio | 44195 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
The incidence of high or low output stoma will be determined from the Alfred SmartBag dashboard. A historical report will be analysed at 30, 60 and 90 days. |
| 30, 60 and 90 days |
| Number of clinically significant dehydration events within 30, 60 and 90 days of surgery | Clinically significant dehydration events will be determined from the hospital patient record. This will be checked by the research team on the 30th, 60th and 90th postoperative day. | 30, 60 and 90 days |
| Emergency department visits within 30, 60 and 90 days of surgery | Emergency department visits will be determined from the hospital patient record. This will be checked by the research team on the 30th, 60th and 90th postoperative day. | 30, 60 and 90 days |
| Hydration Clinic visits within 30, 60 and 90 days of surgery | Hydration clinic visits will be determined from the hospital patient record. This will be checked by the research team on the 30th, 60th and 90th postoperative day. | 30, 60 and 90 days |
| Surgical Site Infection rates within 30, 60 and 90 days of surgery | Surgical Site Infection will be determined from the hospital patient record. This will be checked by the research team on the 30th, 60th and 90th postoperative day. | 30, 60 and 90 days |
| The incidence of patient-reported stoma accidents (leakage) within 30, 60 and 90 days of surgery | The incidence of patient-reported stoma accidents (leakage) will be determined by analysis of the Patient Coach record. This will be checked by the research team on the 30th, 60th and 90th postoperative day. | 30, 60 and 90 days |
| Patient reported satisfaction when using the Alfred SmartBag System | Patient reported satisfaction will be determined by thematic analysis of the Patient Coach record. This will be checked by the research team on the 30th, 60th and 90th postoperative day. | 30, 60 and 90 days |
| Patient reported quality of life when using the Alfred SmartBag System | Patient reported quality of life will be determined by thematic analysis of the Patient Coach record. This will be checked by the research team on the 30th, 60th and 90th postoperative day. | 30, 60 and 90 days |